These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 33781701

  • 1. Continuous glucose monitoring indices predict poor FEV1 recovery following cystic fibrosis pulmonary exacerbations.
    Pallin M, Kumar S, Daley C, Dawadi S, Leong P, Carr E, Soldatos G.
    J Cyst Fibros; 2021 Sep; 20(5):785-791. PubMed ID: 33781701
    [Abstract] [Full Text] [Related]

  • 2. Continuous glucose monitoring and advanced glycation endproducts for prediction of clinical outcomes and development of cystic fibrosis-related diabetes in adults with CF.
    Scully KJ, Brenner L, Martin K, Ruazol M, Sawicki GS, Uluer A, Neuringer I, Yonker LM, Sicilian L, Putman MS.
    Front Endocrinol (Lausanne); 2024 Sep; 15():1293709. PubMed ID: 38379863
    [Abstract] [Full Text] [Related]

  • 3. The effect of oral and intravenous antimicrobials on pulmonary exacerbation recovery in cystic fibrosis.
    VanDevanter EJ, Heltshe SL, Skalland M, Lechtzin N, Nichols D, Goss CH.
    J Cyst Fibros; 2021 Nov; 20(6):932-936. PubMed ID: 33685776
    [Abstract] [Full Text] [Related]

  • 4. Lung function changes before and after pulmonary exacerbation antimicrobial treatment in cystic fibrosis.
    Wagener JS, VanDevanter DR, Konstan MW, Pasta DJ, Millar SJ, Morgan WJ.
    Pediatr Pulmonol; 2020 Mar; 55(3):828-834. PubMed ID: 31746561
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Continuous Glucose Monitoring and HbA1c in Cystic Fibrosis: Clinical Correlations and Implications for CFRD Diagnosis.
    Scully KJ, Sherwood JS, Martin K, Ruazol M, Marchetti P, Larkin M, Zheng H, Sawicki GS, Uluer A, Neuringer I, Yonker LM, Sicilian L, Wexler DJ, Putman MS.
    J Clin Endocrinol Metab; 2022 Mar 24; 107(4):e1444-e1454. PubMed ID: 34850006
    [Abstract] [Full Text] [Related]

  • 8. Glycemic control and FEV1 recovery during pulmonary exacerbations in pediatric cystic fibrosis-related diabetes.
    Okoniewski W, Hughan KS, Weiner GA, Weiner DJ, Forno E.
    J Cyst Fibros; 2020 May 24; 19(3):460-465. PubMed ID: 31980357
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Early assessment of glucose abnormalities during continuous glucose monitoring associated with lung function impairment in cystic fibrosis patients.
    Leclercq A, Gauthier B, Rosner V, Weiss L, Moreau F, Constantinescu AA, Kessler R, Kessler L.
    J Cyst Fibros; 2014 Jul 24; 13(4):478-84. PubMed ID: 24359972
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Re-examining baseline lung function recovery following IV-treated pulmonary exacerbations.
    Heltshe SL, Russell R, VanDevanter DR, Sanders DB.
    J Cyst Fibros; 2023 Sep 24; 22(5):864-867. PubMed ID: 36803635
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Pseudomonas aeruginosa antimicrobial susceptibility test (AST) results and pulmonary exacerbation treatment responses in cystic fibrosis.
    VanDevanter DR, Heltshe SL, Hilliard JB, Konstan MW.
    J Cyst Fibros; 2021 Mar 24; 20(2):257-263. PubMed ID: 32505525
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.